White House Blocks Fauci From Testifying to Congressional Panel
(Bloomberg) -- The Trump administration has barred Anthony Fauci, the scientist who's leading the U.S. response to the coronavirus pandemic, from testifying before a congressional hearing next Wednesday.
Fauci had been sought as a witness for a House Appropriations Committee subcommittee that was looking into the U.S. response to the pandemic, according to Evan Hollander, a committee spokesman.
“We have been informed by an administration official that the White House has blocked Dr. Fauci from testifying,” Hollander said on Friday afternoon.
The White House later confirmed that Fauci, the director of the National Institute of Allergy and Infectious Diseases, would not be appearing.
”While the Trump administration continues its whole-of-government response to Covid-19, including safely opening up America again and expediting vaccine development, it is counter-productive to have the very individuals involved in those efforts appearing at congressional hearings,” White House spokesman Judd Deere said in a statement. “We are committed to working with Congress to offer testimony at the appropriate time.”
Earlier: Coronavirus Likely to Generate Telltale Signs, Fauci Says
Fauci has become familiar to millions of Americans through his appearances at White House briefings of the coronavirus task force. His measured, detailed responses to reporters' questions have sometimes put him at odds with President Donald Trump, who has been eager to begin easing coronavirus social distancing guidelines.
Trump spoke for 28 hours in 35 briefings between March 16 and April 26, according to a Washington Post analysis. Fauci spoke for just over two hours at 22 of the briefings during that stretch, the analysis found.
©2020 Bloomberg L.P.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
